A Meta-Analysis of Danhong Injection in the Treatment of Vascular Dementia

Jianhua Chen, Wenzhi Hao, Meichen ZhouJournal of Biosciences and Medicines 2019 · DOI

TL;DR

This meta-analysis suggests that Danhong injection, a traditional Chinese medicine, when used in conjunction with conventional chemotherapy, offers a significant therapeutic advantage in treating vascular dementia (VD). The findings indicate improved patient outcomes and quality of life, positioning Danhong injection as a promising auxiliary treatment.

What Problem Does This Paper Address?

Vascular dementia (VD) is a significant cause of intellectual impairment, stemming from cerebrovascular diseases. It severely impacts patients' quality of life and places a considerable burden on families and society. Despite its prevalence, VD has a poor prognosis, and there's a lack of ideal therapeutic drugs. Current treatments primarily focus on improving cerebral circulation and brain metabolism. Danhong injection, derived from Salvia miltiorrhiza and safflower, has shown potential in improving microcirculation and protecting brain tissue. However, existing clinical trials are often small-scale and lack systematic analysis, necessitating a comprehensive evaluation of its efficacy in VD treatment.

Methods

The researchers conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating Danhong injection for VD. They searched multiple databases (CNKI, VIP, CBM, MEDLINE, PubMed, SCI Expanded) for relevant literature published up to December 31, 2018. Inclusion criteria specified RCTs, specific diagnostic criteria for VD, the use of Danhong injection combined with conventional chemotherapy in the experimental group, and conventional chemotherapy alone in the control group. Outcome measures included treatment effectiveness, Mini-Mental State Examination (MMSE) scores, and Activities of Daily Living (ADL) scores. Literature screening and quality assessment were performed independently by two investigators using the Cochrane System Evaluator's Handbook. Meta-analysis was carried out using RevMan 5.0 software, employing fixed-effect or random-effect models based on heterogeneity tests.

Datasets

Not discussed in the paper. The paper analyzes data from 16 previously published studies.

Key Insights and Ideas

  • Synergistic Effect: The core insight is that Danhong injection, when combined with conventional treatments, appears to offer a synergistic benefit beyond chemotherapy alone for VD patients.
  • Multi-faceted Improvement: The positive effects extend beyond just cognitive scores, suggesting improvements in overall treatment efficacy and patient quality of life.
  • Need for Rigorous Trials: The study highlights the limitations of existing research, emphasizing the need for larger, multi-center, double-blind RCTs with standardized outcome measures to solidify these findings.

Key Results

  • Overall Efficacy: A meta-analysis of seven studies involving 583 patients showed that Danhong injection combined with conventional chemotherapy significantly improved the effectiveness rate of VD treatment compared to conventional chemotherapy alone. The odds ratio was 3.13 (95% CI [2.02, 4.85], P < 0.0001).
  • Cognitive Improvement (MMSE): Twelve studies with 1116 patients indicated that Danhong injection combined with conventional chemotherapy led to a statistically significant improvement in MMSE scores. The standardized mean difference (SMD) was 1.76 (95% CI [0.67, 2.85], P = 0.002).
  • Quality of Included Studies: The study noted limitations in the quality of the included literature, with only a few studies clearly describing randomization methods and none reporting blinding.
  • Publication Bias: A funnel plot analysis suggested potential publication bias among the included studies.

Limitations and Future Work

The authors acknowledge several limitations:

  • Low Quality of Included Literature: Many studies lacked detailed descriptions of randomization, allocation concealment, and blinding, which can introduce bias.
  • Small Sample Sizes and Heterogeneity: The meta-analysis was based on a relatively small number of studies and patients. Significant heterogeneity was observed in the MMSE score analysis, potentially due to variations in chemical drugs used, dosages, treatment durations, and scoring methods across studies.
  • Publication Bias: The funnel plot indicated a possibility of publication bias, meaning studies with positive results might be more likely to be published.

Given these limitations, the authors strongly recommend the development of large-sample, multi-center, randomized double-blind controlled trials with unified outcome indicators to further validate the efficacy and safety of Danhong injection in patients with VD.

Summary updated

Abstract

Objectives: To evaluate the efficacy of Danhong injection in the treatment of vascular dementia. Methods: CNKI, VIP, CBM, MEDLINE, PubMed, and SCI Expanded databases were searched, and the clinical research literature of Danhong injection in the treatment of vascular dementia was collected. Literature screening and literature quality assessment were performed independently by two investigators based on inclusion criteria and the Cochrane System Evaluator’s Handbook version 5.0.0. Meta-analysis was performed using RevMan 5.0 software. Results: A total of 16 studies were included in a total of 1383 patients. Meta-analysis showed that Danhong injection combined with conventional chemotherapy can reduce the incidence of vascular dementia compared with conventional chemotherapy alone (odds ratio 3.13, 95% CI2.02 to 4.85, P < 0.0001), improved Mini-mental State Examination (MMSE)) score (SDD 1.76, 95% CI 0.67 to 2.85, P = 0.002). Conclusion: Danhong transfusion combined with chemical drugs for the treatment of vascular dementia is superior to the simple treatment of chemical drugs, which can improve the efficacy and quality of life of patients, indicating that Danhong injection has an auxiliary effect on the treatment of vascular dementia.
BibTeX
@article{chen2019meta,
  author = {Jianhua Chen and Wenzhi Hao and Meichen Zhou},
  title = {{A Meta-Analysis of Danhong Injection in the Treatment of Vascular Dementia}},
  journal = {Journal of Biosciences and Medicines},
  year = {2019},
  doi = {10.4236/jbm.2019.76011},
}
Figure